All Stories

  1. Assessment of Biochemical Determinants in Multiple Sclerosis Patients Following the Oral Administration of β-D-Mannuronic Acid (M2000)

    Article • Current Drug Discovery Technologies, September 2021, Bentham Science Publishers

    payam saadat, Abbas Mirshafiey, Mohamad Reza Nikouei Moghaddam